Cargando…
microRNAs as Promising Biomarkers of Platelet Activity in Antiplatelet Therapy Monitoring
Given the high morbidity and mortality of cardiovascular diseases (CVDs), novel biomarkers for platelet reactivity are urgently needed. Ischemic events in CVDs are causally linked to platelets, small anucleate cells important for hemostasis. The major side-effect of antiplatelet therapy are life-thr...
Autores principales: | Krammer, Teresa L., Mayr, Manuel, Hackl, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278969/ https://www.ncbi.nlm.nih.gov/pubmed/32423125 http://dx.doi.org/10.3390/ijms21103477 |
Ejemplares similares
-
Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects
por: Krammer, Teresa L., et al.
Publicado: (2022) -
Comprehensive Characterization of Platelet-Enriched MicroRNAs as Biomarkers of Platelet Activation
por: Krammer, Teresa L., et al.
Publicado: (2022) -
Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring
por: Procyk, Grzegorz, et al.
Publicado: (2022) -
MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review
por: Czajka, Pamela, et al.
Publicado: (2021) -
Serum MicroRNAs Are Promising Novel Biomarkers
por: Gilad, Shlomit, et al.
Publicado: (2008)